Vicarious Surgical (NYSE:RBOT) today announced a new hospital collaboration and reported first-quarter financial results. The company inked a deal with UMass Memorial Medical Center intended to support adoption and utilization of its robotic system. With the latest developments at the company, co-founder and CEO Adam Sachs says the company is moving closer to bringing its […]
Vicarious Surgical
Vicarious Surgical president to transition to board role
Vicarious Surgical (NYSE:RBOT) says President Randy Clark will transition into a board seat at the surgical robotics company. In a news release posted yesterday, the Waltham, Massachusetts–based company said that Clark’s exit from the president role will be effective on April 25, pending customary conflict checks. Clark, who previously held executive positions at Flex and […]
Vicarious Surgical appoints a new CFO
Vicarious Surgical (NYSE:RBOT) announced today that it named Sarah Romano as its next chief financial officer (CFO). Romano’s appointment goes into effect on April 1, 2025. She succeeds William Kelly, who announced plans to leave the company in December to pursue other career opportunities. Romano’s responsibilities include overseeing Vicarious Surgical’s financial strategy. According to a […]
10 surgical robotics companies you need to know
Intuitive remains the dominant surgical robotics company — but other companies with savvy strategies are generating buzz and raising money. Surgical robotics experts agree that the most promising technologies provide robotic surgery options that don’t necessarily clash with Intuitive — the decades-long leader in soft-tissue surgery, which launched its next-gen da Vinci 5 system last […]
Vicarious Surgical COO plans to retire
Vicarious Surgical (NYSE:RBOT) announced today that John Mazzola, its chief operating officer (COO), plans to retire. Mazzola’s retirement goes into effect on April 1, 2025. He plans to continue to serve as COO until that date, at which time he hands his responsibilities over to company president Randy Clark. In May 2023, Mazzola received a […]
Vicarious Surgical CFO departs, surgical robot timeline is unchanged
Vicarious Surgical (NYSE:RBOT) announced that CFO William Kelly plans to leave the company to pursue other career opportunities. Kelly joined the Waltham, Massachusetts-based company as CFO in January 2021. About four years later, Kelly expects to depart on Jan. 2, 2025. He plans to assist the company to ensure minimal disruption and a successful transition […]
Layoffs in medtech: These companies recently reduced their workforce
Medtech layoffs are picking up as 2024 draws to a close. Sean Whooley, Associate Editor, and Chris Newmarker, Editor-in-Chief The medical device industry is closing out the year with a fresh round of layoffs. At this point, MassDevice has reported on more than 22,000 medtech job cuts across the industry since mid-2022. (Have a tip […]
Vicarious Surgical says first surgical robot trials remain on track, analysts remain neutral
Vicarious Surgical (NYSE:RBOT) announced third-quarter results that included an update on planned clinical trials for its surgical robot. Waltham, Massachusetts–based Vicarious develops its Version 1.0 (V1.0) robot aimed at increasing the efficiency of surgical procedures. The company hopes to improve patient outcomes and reduce healthcare costs. With a novel approach, V1.0 uses proprietary, human-like surgical […]
Vicarious Surgical announces new hospital partnership for surgical robot
Vicarious Surgical (NYSE:RBOT) announced today that it signed a strategic development agreement with LSU Health New Orleans. LSU Health New Orleans is Louisiana’s flagship and most comprehensive academic health sciences center, Vicarious said in a news release. The center educates the majority of Louisiana’s healthcare professionals. It partners with University Medical Center, which operates a […]
Vicarious Surgical announces reverse stock split
Vicarious Surgical (NYSE:RBOT) announced that it intends to effect a 1-for-30 reverse stock split following shareholder approval. Shareholders voted in favor of the split at its annual meeting on June 10. The Waltham, Massachusetts-based surgical robot maker’s board of directors determined the final ratio within a range authorized by shareholders. Vicarious says it intends for […]
Vicarious Surgical still expects to submit surgical robot to FDA in 2026
Vicarious Surgical (NYSE:RBOT) management offered an update on the development timeline of its surgical robot as part of its fourth-quarter earnings. Previous expectations earmarked mid-2024 for first-in-human trials and fiscal 2025 for de novo clearance submission. However, CEO Adam Sachs pushed V1.0’s timeline back in November 2023. The company outlined plans for a build and […]
